Alternative venlafaxine kinetics in overdose

Nigel Langford, Una Martin, M Ruprah, Robin Ferner

Research output: Contribution to journalArticle

13 Citations (Scopus)


The pharmacokinetics of venlafaxine in therapeutic doses is well established. It is metabolized by the cytochrome P450 enzymes including CYP2D6. The toxicokinetics in overdose is less well known. Case report: A 33-year-old Caucasian female who ingested 3.0 g venlafaxine, and 210 mg zolpidem. The patient remained symptomatic for the following 24 h. Plasma pharmacokinetic analysis demonstrated a prolonged elimination half-life of venlafaxine, estimated to be 15.3 h. We postulate that the patient was a slow metabolizer of substrates for CYP2D6, an enzyme known to exhibit polymorphism.
Original languageEnglish
Pages (from-to)465-467
Number of pages3
JournalJournal of Clinical Pharmacy and Therapeutics
Issue number6
Publication statusPublished - 1 Dec 2002


  • metabolism
  • CYP2D6
  • overdose
  • pharmacokinetics
  • venlafaxine


Dive into the research topics of 'Alternative venlafaxine kinetics in overdose'. Together they form a unique fingerprint.

Cite this